Elizabeth Galbreath

Elizabeth Galbreath

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Pathology
AD Scientific Index ID: 4404527
武田薬品工業株式会社
person_outline Elizabeth Galbreath's MOST POPULAR ARTICLES
1-) FGF-21 as a novel metabolic regulatorA Kharitonenkov, TL Shiyanova, A Koester, AM Ford, R Micanovic, ...The Journal of clinical investigation 115 (6), 1627-1635, 200522062005
2-) Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasiaSG Rane, P Dubus, RV Mettus, EJ Galbreath, G Boden, EP Reddy, ...Nature genetics 22 (1), 44-52, 19998641999
3-) Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiologyMA McCall, RG Gregg, RR Behringer, M Brenner, CL Delaney, ...Proceedings of the National Academy of Sciences 93 (13), 6361-6366, 19964141996
4-) Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitorGH Searfoss, WH Jordan, DO Calligaro, EJ Galbreath, LM Schirtzinger, ...Journal of Biological Chemistry 278 (46), 46107-46116, 20034382003
5-) Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.A Messing, MW Head, K Galles, EJ Galbreath, JE Goldman, M BrennerThe American journal of pathology 152 (2), 391, 19982951998